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ABSTRACT 
Introduction: Polycystic ovary syndrome (PCOS) is an endocrine, reproductive and metabolic disorder and a major cause of infertility in 
women. Testosterone propionate (TP) is used to induce PCOS in rats. High calorie diet causes metabolic changes, oxidative stress and PCOS. 
Sitagliptin (STG) is an inhibitor of dipeptide peptidase (DPP) 4 enzyme used in the treatment of type 2 diabetes. Objective: The aim of the study 
is to investigate the effect of high fat, high fructose diet (HFFD) on TP induced PCOS rats and the role of STG on oxidative stress and 
inflammation in PCOS. Materials and methods: PCOS was induced by administration of TP to normal pellet and HFFD fed rats for 43 days. STG 
(i.p.) was given for the last 15 days to both groups of rats. Vaginal smear, parameters of oxidative stress, antioxidants and inflammation (TNF-α 
and IL-6) in ovary were analyzed. Results: Vaginal smear from TP rats consisted of persistent leucocytes, a characteristic of PCOS. All the TP 
administered rats registered significanty elevated levels of glucose, lipids, oxidative stress and inflammatory markers and reduced levels of 
antioxidants compared to CON rats. STG treatment to PCOS rats reduced hyperglycemia and hyperlipidemia, oxidative stress and inflammation 
and improved estrus cycle. Conclusion: High energy diet aggravated TP-induced changes in oxidative stress and inflammatory cytokines in 
ovary. STG recuperated the changes induced by TP, suggesting that STG holds potential for PCOS management.  
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INTRODUCTION 
Polycystic ovary syndrome (PCOS) is an endocrine disease 
associated with reproductive and metabolic disorders 
affecting 3.4% women globally.[1] Endocrine disturbances 
like hyperandrogenism, increased luteinizing hormone (LH) 
levels, luteinizing hormone:follicular stimulating hormone 
ratio (LH:FSH ratio) and metabolic changes like 
hyperinsulinemia, hyperglycemia, insulin resistance and 
dyslipidemia are observed in PCOS.[2] The phenotypic 
changes include acne, hirsuitsm, amenorrhea, irregular 
menstruation and infertility.[3] 
Oxidative stress is a pathophysiological condition in which 
there is loss of balance between free radicals generation and 
antioxidants levels in living cells. Oxidative stress is 
considered as one of the potential inducer of PCOS 
pathogenesis.[4] Oxidative stress in PCOS is found to affect 
ovarian functions like oocyte maturation, fertilization and 
embryo development.[5] Studies have evidenced increased 
oxidative stress markers and reduced antioxidants in human 
and rat models of PCOS. [6,7]  
The treatment and management of PCOS involves both non-
pharmacological and pharmacological approaches. Non-
pharmacological approaches like diet and exercise, in many 
PCOS patients are shown to be ineffective.[8] Literature 
suggests that treatment with various pharmaceutical drugs 
such as metformin, clomiphene citrate, letrozole, anti-
androgen drugs and gonadotropin are useful but have 
several side effects.[9,10,11] Therefore, it becomes essential to 
explore alternative drugs for the management of PCOS. 
Sitagliptin (STG) is used in the treatment of type 2 diabetes 
(T2D).  The pharmacological action of STG involves the 
inactivation of dipeptide peptidase 4 enzyme (DPP) 4.[12]  
DPP 4 removes the N-terminal dipeptide of incretins like 
glucagon like peptide-1 (GLP-1) which is known to lower 
blood glucose by increasing the insulin secretion by β-cells. 
STG by inhibiting DPP 4 increases the bioavailability of GLP-
1 causing glucose homeostasis. Besides, glucose lowering 
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effect, antioxidant and anti-inflammatory potential of STG 
have also been reported.[13,14] 
Animal models of PCOS use androgens to induce PCOS. 
Recently, it is shown that addition of high fat diet to 
dihydroepiandrostenedione (DHEA) produced exaggerated 
endocrine and metabolic changes than when DHEA was 
administered alone.[15] Moreover PCOS subjects are obese 
due to visceral adiposity. Based on these observations, we 
hypothesize that high fat, high fructose diet (HFFD) would 
enhance the changes induced by testosterone propionate 
(TP) and STG may have beneficial effects in PCOS. The 
present study was therefore undertaken to analyze the 
impact of high calorie diet on oxidative stress, antioxidants 
and inflammatory cytokine expression in TP induced PCOS 
animals and to explore the recuperative effects of STG in 
PCOS rats.  
MATERIALS AND METHODS 
Chemicals, reagents and solvents 
TP and crystal violet stain were obtained from Himedia 
Laboratories Pvt. Ltd., Mumbai, India. STG was purchased 
from Merck Pvt. Ltd., USA respectively. Kits for estimation of 
glucose and insulin were obtained from Agappe Diagnostics 
Pvt. Ltd., Kerala, India and Accubind, Monobind Inc., CA, USA 
respectively. Supersensitive polymer-horseradish 
peroxidase immunohistochemistry detection kit was 
purchased from Biogenex laboratories, San Ramon, CA, USA. 
Fine chemicals, solvents and other reagents were obtained 
from Himedia Laboratories Pvt. Ltd., Mumbai, India and 
Sisco Research Laboratories Pvt. Ltd., Mumbai, India. 
Diet preparation 
HFFD was prepared every day with the following ingredients 
(g/100 g): fructose 45.0, groundnut oil 10.0, beef tallow 
10.0, casein 22.5, DL-methionine 0.3, wheat bran 5.5, vitamin 
mixture 1.2, and mineral mixture 5.5. The standard rat pellet 
contained 60% (w/w) starch, 22.08% (w/w) protein and 
4.38% (w/w) fat. The energy content of HFFD was 471.25 
cal/100 g while that of control diet was 382.61 cal/100 g.  
Animals and housing  
The study was approved by the Institutional Animal Ethics 
Committee (IAEC) of Annamalai University (No. 
160/1999/CPCSEA/1134) in accordance with the Indian 
National Law on Animal Care and use. Female albino Wistar 
rats weighing 50–75 g of age 21 days were used for the 
study. The animals were procured from Biogene, Laboratory 
Animal Facility, Bengaluru, India and maintained in the 
Central Animal House, Rajah Muthiah Medical College and 
Hospital, Annamalai Nagar. The animals were maintained 
under standard housing conditions (22-24 °C) in 
polypropylene cages under 12 h light/dark cycle. The 
experiments were performed in accordance with the 
guidelines of the Committee for the Purpose of Control and 
Supervision of Experiments on Animals (CPCSEA).  
Experimental design and treatment 
The animals were allowed to acclimatize for a week, after 
which the animals were randomly distributed into five 
groups each comprising of six animals (n = 6) and were 
maintained for 43 days. 
Group 1: Animals received normal pellet and served as 
control group  
Group 2: Animals received normal pellet and TP for 43 days  
Group 3: Animals received HFFD and TP for 43 days 
Group 4: Animals received normal pellet, TP for 43 days and 
STG for the last 15 days 
Group 5: Animals received HFFD and TP for 43 days and STG 
for the last 15 days.  
           The animals had free access to diet and water. TP was 
administered at the dose of 1 mg/100 g bw/day in olive oil, 
i.p. and STG at the dose of 30 mg/kg bw/day in 0.9 % saline 
by intragastric intubation. The dosage used is based on 
previous reports.[16,17] Body weight of the animals was 
measured the beginning and at the end of the study. Estrus 
cycle of rats was monitored by microscopic examination of 
the vaginal smear which was collected early morning from 
8th day till 43rd day. At the end of the 43 days, rats were 
fasted overnight, anaesthetized with ketamine 
hydrochloride (30 mg/kg, i.p.) and killed by cervical 
dislocation.  
Vaginal smear preparation 
The vaginal smear was obtained using aseptic moist (in 0.9% 
saline) cotton swab rolled delicately around the vaginal 
opening and was transferred onto a glass slide. The slides 
were allowed to dry at room temperature and stained with 
crystal violet followed by gentle wash to remove the excess 
stain. The stained slides were dried, fixed using glycerol and 
covered with cover slip.[18] The image was taken under 
Olympus CX 4 microscope [40X], (Olympus Corporation, 
Tokyo, Japan). 
Sampling of blood and tissue  
Blood was collected from the retino-orbital plexus in tubes 
containing the anticoagulant EDTA for separation of plasma 
by centrifugation (1500×g, 15 min). Red blood cells were 
further processed to prepare hemolysate for the assay of 
enzymatic and non-enzymatic antioxidants.  Ovary tissue 
was dissected and washed immediately in ice-cold saline 
(0.9% sodium chloride). Ovary homogenate (10%) was 
prepared in ice-cold 0.1 M Tris-HCl buffer, pH 7.4. Portions 
from ovary tissue were placed in 10% formalin for 
performing immunohistochemical studies.  
Estimation of biochemical parameters 
The levels of glucose and insulin in plasma were determined 
using kits. The levels of total cholesterol (TC) and 
triglyceride (TG) in plasma and ovary were measured by the 
methods of Zlatkis et al. (1953) [19] and Foster et al. 
(1973).[20] 
Evaluation of oxidative stress  
Thiobarbituric acid reactive substances (TBARS) in plasma 
and ovary homogenate was measured by the method of 
Niehaus and Samuelsson (1968).[21]  Lipid hydroperoxides 
(LHP) levels were quantitated by the method of Jiang et al. 
(1992).[22] The activities of superoxide dismutase (SOD), 
catalase (CAT) and glutathione peroxidase (GPx) and the 
level of glutathione (GSH) were assayed in hemolysate and 
ovary homogenate by methods described elsewhere.[23] 
Analysis of inflammatory markers 
The cytokines TNF-α and IL-6 were assayed using 
immunohistochemistry. For this, the ovary sections was 
deparaffinized by baking for 1 h at 60°C followed by 
dewaxing with xylene. Sections were then rehydrated with 
graded concentrations of isopropyl alcohol and subjected to 
antigen retrieval for 3 min using citrate buffer (0.1M, pH 
6.0). Antigen retrieved sections were incubated in peroxide 
blocking reagent for 10 min and then rinsed with phosphate 
buffer followed by incubation for 10 min with power block 
solution. Nonspecific binding was minimized by washing the 
Dipti & Anuradha                                                                                              Journal of Drug Delivery & Therapeutics. 2019; 9(4-s):244-251 
ISSN: 2250-1177                                                                                  [246]                                                                                 CODEN (USA): JDDTAO 
sections with 3% BSA in phosphate-buffered saline for 30 
min. Sections were incubated overnight with the primary 
antibodies. Different dilutions of primary antibodies were 
used:  TNF-α (1:100) and IL-6 (1:100). The sections were 
rinsed with phosphate buffer and incubated with super 
enhancer reagent for 30 min. The rinsed sections were 
incubated with Polymer-HRP reagent. The sections were 
washed with buffer and incubated with 3, 3′-
diaminobenizidine (DAB) substrate solution for 5 min and 
counterstained with Mayer's hematoxylin. The sections were 
photographed under the Olympus CX 4 microscope [40X], 
(Olympus Corporation, Tokyo, Japan). 
Statistical analysis 
SPSS software, version 20.0 (SPSS Inc, Chicago, IL, USA) was 
used for statistical analyses. Significant difference in means 
between the groups was analyzed using one-way ANOVA 
followed by Tukey's test for multiple comparisons. Two-way 
ANOVA was used to evaluate the interactive effect of HFFD 
and STG treatment on oxidative stress markers and 
antioxidants. Values are presented as means ± SD (n = 6). A 
value of p < 0.05 was considered to be statistically 
significant. 
 
 
RESULTS 
Confirmation of PCOS 
Induction of PCOS was confirmed by examining the vaginal 
smear cytology. The distinct cell types associated during 
different stages of estrus cycle are epithelial cells with few 
keratinocytes in the proestrus stage; keratinocytes in the 
estrus; keratinocytes, leukocytes and epithelial cells in the 
metestrus; predominanlty leucocytes in the diestrus.  
Figs. 1a-h show the representative photographs of vaginal 
smears obtained from the different experimental groups. 
Figs. 1a-d represent vaginal smear from CON group. The 
presence of nucleated epithelial cells with few keratinocytes 
are seen in Fig. 1a signifying proestrus stage. Fig. 1b shows 
the presence of keratinocytes signifying estrus stage. Three 
distict cell types namely keratinocytes, leukocytes and 
epithelial cells are found in Fig. 1c indicating metestrus 
stage. Presence of leucocytes in Fig. 1d indicates diestrus 
stage. Dominance of leucocytes was noted in CD+TP group 
and HFFD+TP group (Figs. 1e and 1f respectively). The 
leucocytes were denser in HFFD+TP rats (Fig. 1f) than 
CD+TP rats (Fig. 1e). STG treated TP groups display mainly 
epithelial cells and very few leukocytes indicating the 
recovery of PCOS rats from diestrus to proestrus stage (Figs. 
1g and 1h). 
  
 
Fig. 1. Representative photographs of different cell types of vaginal smears obtained from experimental rats during 
estrus cycle. a) Appearance of nucleated epithelial cells and keratinocytes in proestrus stage from control rats. b) Presence of 
keratinocytes in estrus stage from control rats. c) Presence of keratinocytes, leukocytes and epithelial cells in metestrus stage 
from control rats. d) Occurrence of leucocytes in diestrus stage from control rats. e) Occurrence of persistent leucocytes from 
CD+TP rats. f) Existence of persistent leucocytes from HFFD+TP rats. g) Appearance of epithelial cells and few leukocytes from 
CD+TP+STG treated rats. h) Appearance of epithelial cells and leukocytes from HFFD+TP+STG treated rats. K-keratinocytes; 
NE-nucleated epithelial cells; L-leukocytes. [magnification 40X]. Scale bar, 10 μm.  
Body weight  
Table 1 shows the initial and final body weights of the 
animals. The initial body weight of the animals was between 
50-52 g. A significant gain in final body weight of rats was 
observed in all the groups. TP administered rats maintained 
on HFFD gained more body weight than those given normal 
pellet. STG+TP treated rats maintained on HFFD (Group 5) 
or normal diet (Group 4) showed decrease in body weight 
compared to respective STG untreated TP administered rats 
(Group 2 and 3 respectively). Diet and treatment showed 
independent as well as interactive effect on final body 
weight (Table 1). 
Glucose and insulin 
The levels of glucose and insulin from plasma are provided 
in Table 1. Elevated levels of glucose and insulin were 
observed in all the TP given animals compared to CON 
animals. Significant rise in the levels of both glucose and 
insulin were noted in TP animals placed on HFFD diet 
(Group 3) compared to TP animals given normal diet (Group 
2). However, STG treated groups on either diet showed 
restoration of the levels compared STG untreated groups. An 
independent effect of diet and treatment was seen for both 
glucose and insulin levels but showed no interactive effect 
(Table 1). 
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Table 1.  Initial and final body weight, glucose and insulin levels of experimental rats 
CON- normal pellet fed rats; CD+TP- normal pellet fed rats+TP; HFFD+TP- high fat, high fructose diet fed rats+TP; CD+TP+STG- 
normal pellet fed rats+TP+STG treated; HFFD+TP+STG- HFFD fed rats+TP+STG treated; INTER-Interaction; NS-not significant. 
Values are means ± SD of rats. Values sharing different superscripts are significantly different from one another . One-way 
ANOVA was used to determine the significance of means between groups. p < 0.05 was considered significant. Two-way ANOVA 
was used to evaluate the effect of HFFD and STG treatment between the groups. p < 0.05 was considered significant. 
 
Lipids 
Table 2 shows TC and TG levels in ovary which were found to 
be significantly elevated in all TP administered animals 
compared to CON animals. The increase was more in HFFD 
fed TP rats compared to TP rats given normal pellet. 
Treatment of HFFD+TP and CD+TP groups with STG 
significantly decreased the levels respectively but not upto 
the control level. Diet and treatment independently affected 
TC and TG levels but interactive effect was seen only TG 
(Table 2).  
 
Table 2.  TC and TG levels in ovary of experimental rats 
Groups CON CD+TP HFFD+TP 
 
CD+TP+ST
G 
 
HFFD+TP+ST
G 
Two-Way ANOVA 
DIET        STG       INTER 
Treatment 
Plasma         
TC (mmol/L) 2.40±0.02a 3.42±0.02b 5.42±0.01c 2.85±0.02d 4.86±0.03e P < 0.00 P < 0.00 P < 0.52 
TG (mmol/L) 1.43±0.01a 2.33±0.01b 3.43±0.02c 1.94±0.01d 2.89±0.01e P < 0.00 P < 0.00 P < 0.00 
Ovary 
TC (mg/g tissue) 
 
2.52±0.02a 
 
3.77±0.01b 
 
5.91±0.01c 
 
3.00±0.02d 
 
5.35±0.01e 
 
P < 0.00 
 
P < 0.00 
 
P < 0.00 
TG (mg/g tissue) 1.55±0.01a 2.52±0.01b 3.67±0.03c 2.10±0.01d 3.22±0.01e P < 0.00 P < 0.00 P < 0.11 
CON- normal pellet fed rats; CD+TP- normal pellet fed rats+TP; HFFD+TP- high fat, high fructose diet fed rats+TP; CD+TP+STG- 
normal pellet fed rats+TP+STG treated; HFFD+TP+STG- HFFD fed rats+TP+STG treated; INTER-Interaction; NS-not significant. 
Values are means ± SD of rats. Values sharing different superscripts are significantly different from one another . One-way 
ANOVA was used to determine the significance of means between groups. p < 0.05 was considered significant. Two-way ANOVA 
was used to evaluate the effect of HFFD and STG treatment between the groups. p < 0.05 was considered significant. 
 
Oxidative stress markers  
Table 3 illustrates the oxidative stress markers from plasma 
and ovary of experimental rats. TP administered animals 
exhibited significantly elevated levels of TBARS and LHP 
compared to CON rats. The levels were significantly elevated 
in TP rats maintained on HFFD than those fed normal diet. 
Significant reduction in levels the oxidative stress markers 
was observed in plasma and ovary of STG treated HFFD+TP 
and CD+TP rats compared to groups deprived of STG 
treatment. Two-way ANOVA result showed significant 
independent as well as interactive effects of diet and 
treatment on oxidative stress (Table 3). 
  
 
 
 
 
 
 
Groups        CON     CD+TP   HFFD+TP 
 
CD+TP+STG  HFFD+TP+STG TWO-WAY ANOVA 
 DIET          STG        INTER 
                 Treatment 
Body weight  
Initial body 
weight (g) 
50.11±0.71 51.41±1.06 51.27±0.88 50.99±0.45 51.49±0.85 
p < 
0.00 
NS NS 
Final body 
weight (g) 
67.67±79.27a 79.27±0.55b 91.91±0.86c 71.40±0.81d 86.24±1.21e 
p < 
0.00 
p < 0.00 
p < 
0.00 
Glucose and insulin  
Glucose 
(mg/dL) 
89.38±3.89a 136.44±2.29b 164.09±1.02c 121.80±4.15d 152.38±0.73e p < 0.00 p < 0.00 NS 
Insulin 
(µU/mL) 
15.09±0.80a 25.40± 0.98b 36.12±0.15c 18.57±0.76d 28.51±1.13e p < 0.00 p < 0.00 NS 
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Table 3. Levels of TBARS and LHP in experimental rats 
Groups CON CD+TP HFFD+TP CD+TP+STG 
 
HFFD+TP+STG Two-Way ANOVA 
DIET      STG      INTER 
Treatment 
Plasma        
TBARS 
(µmol/dL) 
1.20±0.02a 4.27±0.05b 4.94±0.02c 2.88±0.02d 3.43±0.02e p < 0.00 p < 0.00 p < 0.001 
LHP 
(nmol/dL) 
1.75±0.02a 4.71±0.02b 5.73±0.02c 3.63±0.01d 4.48±0.02e p < 0.00 p < 0.00 p < 0.00 
Ovary 
TBARS 
(nmol/mg 
protein) 
1.23±0.02a 5.28±0.01b 6.34±0.01c 3.40±0.02d 4.65±0.02e p < 0.00 p < 0.00 p < 0.00 
LHP 
(nmol/mg 
protein)   
2.09±0.01a 
5.54 
±0.02b 
7.50±0.02c 3.96±0.01d 4.95±0.01e p < 0.00 p < 0.00 p < 0.001 
CON- normal pellet fed rats; CD+TP- normal pellet fed rats+TP; HFFD+TP- high fat, high fructose diet fed rats+TP; CD+TP+STG- 
normal pellet fed rats+TP+STG treated; HFFD+TP+STG- HFFD fed rats+TP+STG treated; INTER-Interaction; NS-not significant. 
Values are means ± SD of rats. Values sharing different superscripts are significantly different from one another . One-way 
ANOVA was used to determine the significance of means between groups. p < 0.05 was considered significant. Two-way ANOVA 
was used to evaluate the effect of HFFD and STG treatment between the groups. p < 0.05 was considered significant. 
 
Antioxidants status 
Tables 4 and 5 illustrate the antioxidant status (enzymatic 
and non-enzymatic) in the hemolysate and ovary 
respectively of experimental rats. TP treated animals 
exhibited significantly reduced activities of SOD, CAT, GPx 
and GSH in both hemolysate and ovary as compared to CON 
rats signifying the presence of ROS-antioxidant imbalance. 
Between the diet groups the levels were significantly 
decreased in HFFD+TP rats compared to CD+TP rats. STG 
supplementation in both the diet groups improved the levels 
significantly in hemolysate (Table 4) as well as in ovary 
(Table 5) compared to respective STG untreated groups. The 
result of two-way ANOVA showed independent influence of 
diet and treatment on both enzymatic and non-enzymatic 
antioxidants levels. No interactive effect was seen for levels 
of CAT hemolysate and ovary tissue, GPx in hemolysate, and 
GSH in ovary. 
                  
Table 4. Antioxidants levels in hemolysate of experimental rats 
CON- normal pellet fed rats; CD+TP- normal pellet fed rats+TP; HFFD+TP- high fat, high fructose diet fed rats+TP; CD+TP+STG- 
normal pellet fed rats+TP+STG treated; HFFD+TP+STG- HFFD fed rats+TP+STG treated; INTER-Interaction; NS-not significant. 
Values are means ± SD of rats. Values sharing different superscripts are significantly different from one another . One-way 
ANOVA was used to determine the significance of means between groups. p < 0.05 was considered significant. Two-way ANOVA 
was used to evaluate the effect of HFFD and STG treatment between the groups. p < 0.05 was considered significant. U = enzyme 
concentration required to produce 50% inhibition of chromogen formation in one minute under standard condition.
               
 
 
Groups  CON CD+TP HFFD+TP 
 
CD+TP+STG HFFD+TP+STG Two-Way ANOVA 
DIET    STG     INTER 
Treatment 
SOD (U/mg Hb) 3.89±0.37a 2.37±0.01b 1.27±0.05c 2.75±0.20d 1.99±0.07e P < 0.00 P < 0.00 P < 0.04 
CAT (µmoles of 
H2O2 
consumed/min/
mg Hb) 
44.77±1.53a 32.95±0 .65b 19.66±0.86c 41.44±0.72d 28.78±0.70e P < 0.00 P < 0.00 P < 0.47 
GPx (µmoles GSH 
consumed/min/
mg Hb) 
8.62 ±0.69a 5.57±0.19b 3.93±0.47c 6.52±0.28d 4.71±0.07e P < 0.00 P < 0.00 P < 0.61 
GSH (mg/dL 
plasma) 
21.04±0.59a 15.38±0.34b 8.20±0.50c 17.44±0.26d 12.31±0.34e P < 0.00 P < 0.00 P < 0.00 
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Table 5. Antioxidants levels in ovary of experimental rats 
Groups CON                CD+TP        HFFD+TP    CD+TP+STG   HFFD+TP+STG Two-Way ANOVA 
DIET      STG      INTER 
Treatment 
 
SOD (U/mg protein)  
 
4.01±0.13a 3.07±0.14b 2.06±0.11c 3.84±0.11d 2.59±0.12e p < 0.00 p < 0.00 p < 0.03 
CAT (µmoles of H2O2 
consumed/min/mg 
protein) 
 
45.59±0.49a 26.63±0.67b 14.05±0.62c 35.93±0.56d 23.58±0.42e p < 0.00 p < 0.00 p < 0.64 
GPx (µmoles GSH 
consumed/min/mg  
protein)   
 
6.80±0.07a 4.79±0.09b 2.43±0.06c 5.48±0.16d 3.29±0.05e p < 0.00 p < 0.00 p < 0.04 
GSH (μg/mg plasma) 
44.24±0.83a 28.16±0.51b 17.96±0.67c 34.23±0.92d 24.90±0.19e p < 0.00 p < 0.00 p < 0.12 
CON- normal pellet fed rats; CD+TP- normal pellet fed rats+TP; HFFD+TP- high fat, high fructose diet fed rats+TP; CD+TP+STG- 
normal pellet fed rats+TP+STG treated; HFFD+TP+STG- HFFD fed rats+TP+STG treated; INTER-Interaction; NS-not significant. 
Values are means ± SD of rats. Values sharing different superscripts are significantly different from one another . One-way 
ANOVA was used to determine the significance of means between groups. p < 0.05 was considered significant. Two-way ANOVA 
was used to evaluate the effect of HFFD and STG treatment between the groups. p < 0.05 was considered significant. U = enzyme 
concentration required to produce 50% inhibition of chromogen formation in one minute under standard condition. 
 
Immunohistochemical localization of TNF-α and IL-6 in 
ovary  
Fig. 2 represents the immunohistochemical localization of 
TNF-α (Figs. 2a-e) and IL-6 (Figs. 2f-j) in ovary of 
experimental rats. The expression of TNF-α in ovary was 
more intense in TP treated rats on HFFD (Fig. 2c) as 
compared to rats on normal diet (Fig. 2b). A marked 
reduction in immunoreactivity of TNF-α was observed in STG 
supplemented groups (Figs. 2d and 2e) as compared to STG 
unsupplemented groups (Figs. 2b and 2c). CON rats 
displayed very mild immunoreactivity (Fig. 2a).  
Similarly, increased immunoreactivity for IL-6 in ovary 
tissue was noted in TP administered rats fed with HFFD (Fig. 
2h) as compared to TP rats fed normal pellet (Fig. 2g). The 
intensity of the colour was found to be reduced in STG 
treated groups (Figs. 2i and 2j) compared to STG untreated 
groups (Figs. 2g and 2h). The intensity of immunoreactivity 
was very less in CON group (Fig. 2f) 
 
 
Fig. 2 Representative photomicrographs of immunohistochemical localization of TNF-α and IL-6 in rat ovary. a-e) TNF-
α and f-j) IL-6. CON- normal pellet fed rats; CD+TP- normal pellet fed rats+TP; HFFD+TP- high fat, high fructose diet fed 
rats+TP; CD+TP+STG- normal pellet fed rats+TP+STG treated; HFFD+TP+STG- HFFD fed rats+TP+STG treated. The presence of 
antigen–antibody interaction displayed brown colour and the absence of antigen–antibody interaction displayed 
counterstained haematoxylin colour that appeared blue colour [magnification 40X]. Scale bar-10 μm 
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DISCUSSION 
The study demonstrated two major findings i) 
administration of high calorie diet exaggerates TP induced 
oxidative stress and inflammation and ii) STG alleviates 
oxidative stress and inflammation in ovary of PCOS rats. 
The disruption of the delicate balance between oxidants and 
antioxidant system resulting in oxidative stress has been reported 
by several investigators in PCOS models.[24,25] Oxidative stress 
plays a central role in the progression of female infertility and has 
been shown to affect a variety of physiological functions such as 
folliculogenesis, oocyte maturation, ovarian steroidogenesis, 
ovulation, fertilization, implantation, formation of blastocyst, 
luteolysis and luteal maintenance in pregnancy.[4]  
A study by Nasiri et al. (2015) [26] reported the influence of 
abdominal obesity on oxidative stress in women. Elevated levels 
of lipid peroxides and reduced level of total antioxidant capacity 
were observed in both PCOS and normal women having 
abdominal obesity as compared to normal and PCOS women 
without abdominal obesity. This study suggests that fat 
accumulation plays a contributory role in progression of oxidative 
stress. [26] 
According to Keane et al. (2015) oxidative stress is mainly 
driven by hyperglycaemia and hyperlipidemia.[27] In this study, 
TP rats fed HFFD or normal diet displayed both 
hyperglycaemia and hyperlipidemia resulting in oxidative 
stress. Previous findings have registered that HFFD feeding to 
animals cause decreased activity enzymatic (SOD, CAT and GPx) 
and non-enzymatic (GSH) antioxidants and increased activity of 
oxidative stress markers.[28,29] In this study, HFFD feeding in TP 
rats resulted in elevated levels of oxidative stress markers and 
decreased levels of enzymatic and non-enzymatic antioxidants as 
compared to normal diet fed TP rats which can be attributed to 
hormonal changes induced by TP and metabolic changes induced 
by HFFD.  
TNF-α and IL-6 are capable of regulating the reproductive 
events such as folliculogenesis, ovulation and fertilization.[30] 
Oxidative stress and inﬂammation are proposed to be interlinked. 
ROS generated by oxidative stress act as intracellular messengers 
to induce the synthesis of cytokines via activating the nuclear 
transcription factor (NF-κB-p65) gene which upregulates the 
expression of cytokines.[31] Activation of NF-κB and an increase 
in TNF-α have been described in in PCOS women.[32] The 
expression of TNF-α and IL-6 were increased in all TP 
administered rats compared to control rats and expression 
was more in TP rats on HFFD than those on CD. 
STG restored the levels of enzymatic, non-enzymatic antioxidants 
and oxidative stress status. Thus, STG by virtue of its antioxidant 
and free radical scavenging activities [29,33] is capable of 
modulating antioxidant enzyme activities and suppressing the 
oxidative stress markers in PCOS rats.  The restoration of 
oxidative stress by STG might be due its glucose and lipid lowering 
potential, which was decreased in STG treated groups in our 
study. Studies demonstrated that STG treatment in mice fed 
high fat diet (HFD) lowered the levels of TNF-α and IL-6. [34] 
Normalization of  TNF-α and IL-6 in TP rats following STG 
treatment signifies that apart from its antioxidant and radical 
scavenging activities, STG has anti-inflammatory effects that 
might have blocked or prevented the expression of 
inflammatory cytokines (TNF-α and IL-6).  
CONCLUSION 
The results obtained in this study show that inclusion of high 
energy diet promotes PCOS pathogenesis by aggravating 
oxidative stress and inflammatory cytokine expression. STG 
treatment recovered the levels of antioxidants and reduced 
oxidative stress and inflammation. Therefore, it may be 
concluded that gliptins may offer a therapeutic potential in 
management of oxidative stress in PCOS subjects. 
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